Non-small cell cancer (NSCLC) tumor markers are signs of specific types of tumors. Doctors look for these markers to aid in the diagnosis and treatment of lung cancer. Doctors use several tests to ...

Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...

are associated with improved long-term survival compared to wedge resection for patients with early-stage non-small cell lung cancer (NSCLC). The study analyzed outcomes for more than 32,000 stage ...

A father from Seattle, Washington was shocked and overwhelmed after strangers came together to raise more than $150k for him to go through life-saving cancer treatment.

Findings were similar for lung cancer-specific survival ... randomized trial showed that sublobar resection performed as well as lobectomy for NSCLC tumors ≤2 cm. Around the same time, the ...

Beta carotene supplements may increase the risk of lung cancer in people with a history ... or deactivating tumor suppressor genes (genes that normally restrain cell division and promote DNA ...

Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a preclinical study by Weill Cornell Medicine, Memorial Sloan ...

The researchers found that lobectomy was associated with improved survival compared with sublobar resection (hazard ratio for overall survival [OS] and lung-cancer specific survival [LCSS], 0.87 ...

received a positive recommendation from NICE for NHS use as an adjuvant treatment option after complete tumor resection in adult patients with stage IB-IIIA non-small cell lung cancer (NSCLC ...

Opdualag is a fixed-dose combination of nivolumab, a programmed death receptor-1 blocking antibody, and relatlimab, a lymphocyte activation gene 3 blocking antibody.